Qiagen (QGEN) EBT (2009 - 2025)

Qiagen has disclosed EBT across 17 years of filings, most recently posting $109.2 million for Q4 2025.

• EBT for Q4 2025 came in at $109.2 million, down 13.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $490.3 million (up 304.69% YoY), and the FY2025 annual result was $490.3 million, up 304.69% from the prior year.
• EBT came in at $109.2 million for Q4 2025 at Qiagen, down from $134.7 million in the prior quarter.
• In the past five years, EBT ranged from a high of $195.5 million in Q1 2022 to a low of -$223.5 million in Q2 2024.
• The 5-year median for EBT is $116.5 million (2024), against an average of $106.7 million.
• Across the five-year window, EBT jumped 243.41% in 2021 and slumped 318.39% in 2024, its largest moves.
• Qiagen's EBT stood at $165.4 million in 2021, then slumped by 36.0% to $105.8 million in 2022, then gained by 12.32% to $118.9 million in 2023, then gained by 5.87% to $125.9 million in 2024, then retreated by 13.26% to $109.2 million in 2025.
• The last three EBT figures came in at $109.2 million (Q4 2025), $134.7 million (Q3 2025), and $126.8 million (Q2 2025), per Business Quant data.